Cameron Flower

Postdoctoral Fellow
Department of Data Science, Dana-Farber Cancer Institute

Cameron received his PhD from the Massachusetts Institute of Technology where his thesis work was supervised by Forest White at the Koch Institute for Integrative Cancer Research. In his graduate research, Cameron studied how tumor cell-intrinsic signaling networks contribute to targeted therapy failure using mass spectrometry-based proteomics, drug sensitivity assays, and statistical approaches for analysis of high-dimensional molecular data. In his postdoctoral work, Cameron is interested in the biology underlying the earliest stages of cancer. Using experimental zebrafish models of tumor initiation, his research aims to clarify the earliest molecular events promoting the transition from premalignant to malignant tissue, which may identify opportunities for early cancer interception. His work is jointly supervised by Leonard Zon at Boston Children’s Hospital.

Curriculum Vitae
Personal Information
Name: Cameron Flower
Nationality: American
Address: Dana-Farber Cancer Institute, CLS Building, 3 Blackfan Circle, Boston, MA 02115
Email address: cflower [at] ds.dfci.harvard.edu
Education
2013 – 2017 Bachelor of Science, Biomedical Engineering, University of Connecticut
2017 – 2024 Doctor of Philosophy, Computational and Systems Biology, Massachusetts Institute of Technology
Scientific Career
2014 – 2017 Student Researcher, Neag Comprehensive Cancer Center, University of Connecticut School of Medicine
2016 – 2016 Biomedical Engineering Summer Intern, National Institutes of Health
2018 – 2022 Graduate Teaching Assistant / Head Grader, Analysis of Biomolecular and Cellular Systems (20.320), Massachusetts Institute of Technology
2022 – 2022 Computational Biology Intern, BioNTech US
2018 – 2024 Graduate Research Assistant, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Tehcnology
2024 – present Postdoctoral Fellow, Department of Data Science, Dana-Farber Cancer Institute
2024 – present Postdoctoral Fellow, Division of Hematology/Oncology, Boston Children’s Hospital